ID   DAZ2_HUMAN              Reviewed;         558 AA.
AC   Q13117; Q2KHN6; Q96P41; Q9NR91;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 3.
DT   07-APR-2021, entry version 177.
DE   RecName: Full=Deleted in azoospermia protein 2;
GN   Name=DAZ2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=7670487; DOI=10.1038/ng0895-383;
RA   Reijo R.A., Lee T.Y., Salo P., Alagappan R., Brown L.G., Rosenberg M.,
RA   Rozen S., Jaffe T., Straus D., Hovatta O., de la Chapelle A., Silber S.,
RA   Page D.C.;
RT   "Diverse spermatogenic defects in humans caused by Y chromosome deletions
RT   encompassing a novel RNA-binding protein gene.";
RL   Nat. Genet. 10:383-393(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), GENE STRUCTURE, GENE NOMENCLATURE,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=10936047; DOI=10.1006/geno.2000.6260;
RA   Saxena R., de Vries J.W.A., Repping S., Alagappan R.K., Skaletsky H.,
RA   Brown L.G., Ma P., Chen E., Hoovers J.M.N., Page D.C.;
RT   "Four DAZ genes in two clusters found in the AZFc region of the human Y
RT   chromosome.";
RL   Genomics 67:256-267(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RA   Vogt P.H., Hirschmann P.;
RT   "DAZ2 gene testicular transcript with 14 exon 7 variants expressed in human
RT   testicular tissue.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12815422; DOI=10.1038/nature01722;
RA   Skaletsky H., Kuroda-Kawaguchi T., Minx P.J., Cordum H.S., Hillier L.W.,
RA   Brown L.G., Repping S., Pyntikova T., Ali J., Bieri T., Chinwalla A.,
RA   Delehaunty A., Delehaunty K., Du H., Fewell G., Fulton L., Fulton R.,
RA   Graves T.A., Hou S.-F., Latrielle P., Leonard S., Mardis E., Maupin R.,
RA   McPherson J., Miner T., Nash W., Nguyen C., Ozersky P., Pepin K., Rock S.,
RA   Rohlfing T., Scott K., Schultz B., Strong C., Tin-Wollam A., Yang S.-P.,
RA   Waterston R.H., Wilson R.K., Rozen S., Page D.C.;
RT   "The male-specific region of the human Y chromosome is a mosaic of discrete
RT   sequence classes.";
RL   Nature 423:825-837(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH DAZAP1 AND DAZAP2.
RX   PubMed=10857750; DOI=10.1006/geno.2000.6169;
RA   Tsui S., Dai T., Roettger S., Schempp W., Salido E.C., Yen P.H.;
RT   "Identification of two novel proteins that interact with germ-cell-specific
RT   RNA-binding proteins DAZ and DAZL1.";
RL   Genomics 65:266-273(2000).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11058556; DOI=10.1095/biolreprod63.5.1490;
RA   Reijo R.A., Dorfman D.M., Slee R., Renshaw A.A., Loughlin K.R., Cooke H.,
RA   Page D.C.;
RT   "DAZ family proteins exist throughout male germ cell development and
RT   transit from nucleus to cytoplasm at meiosis in humans and mice.";
RL   Biol. Reprod. 63:1490-1496(2000).
RN   [8]
RP   INTERACTION WITH DAZL.
RX   PubMed=10903443; DOI=10.1016/s0378-1119(00)00219-5;
RA   Ruggiu M., Cooke H.J.;
RT   "In vivo and in vitro analysis of homodimerisation activity of the mouse
RT   Dazl1 protein.";
RL   Gene 252:119-126(2000).
RN   [9]
RP   INTERACTION WITH BOLL.
RX   PubMed=11390979; DOI=10.1073/pnas.131090498;
RA   Xu E.Y., Moore F.L., Reijo Pera R.A.;
RT   "A gene family required for human germ cell development evolved from an
RT   ancient meiotic gene conserved in metazoans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:7414-7419(2001).
RN   [10]
RP   INTERACTION WITH PUM2; DZIP1 AND DZIP3.
RX   PubMed=12511597; DOI=10.1073/pnas.0234478100;
RA   Moore F.L., Jaruzelska J., Fox M.S., Urano J., Firpo M.T., Turek P.J.,
RA   Dorfman D.M., Reijo Pera R.A.;
RT   "Human Pumilio-2 is expressed in embryonic stem cells and germ cells and
RT   interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:538-543(2003).
RN   [11]
RP   REVIEW.
RX   PubMed=12752250; DOI=10.1034/j.1600-0463.2003.11101161.x;
RA   Vogt P.H., Fernandes S.;
RT   "Polymorphic DAZ gene family in polymorphic structure of AZFc locus:
RT   artwork or functional for human spermatogenesis?";
RL   APMIS 111:115-127(2003).
RN   [12]
RP   INVOLVEMENT IN SPGFY2.
RX   PubMed=11095434; DOI=10.1210/jcem.85.11.6929;
RA   Moro E., Ferlin A., Yen P.H., Franchi P.G., Palka G., Foresta C.;
RT   "Male infertility caused by a de novo partial deletion of the DAZ cluster
RT   on the Y chromosome.";
RL   J. Clin. Endocrinol. Metab. 85:4069-4073(2000).
RN   [13]
RP   INVOLVEMENT IN SPGFY2.
RX   PubMed=11870237; DOI=10.1093/molehr/8.3.286;
RA   Fernandes S., Huellen K., Goncalves J., Dukal H., Zeisler J.,
RA   Rajpert De Meyts E., Skakkebaek N.E., Habermann B., Krause W., Sousa M.,
RA   Barros A., Vogt P.H.;
RT   "High frequency of DAZ1/DAZ2 gene deletions in patients with severe
RT   oligozoospermia.";
RL   Mol. Hum. Reprod. 8:286-298(2002).
RN   [14]
RP   INVOLVEMENT IN SPGFY2.
RX   PubMed=12801575; DOI=10.1016/s0015-0282(03)00338-8;
RA   Gianotten J., Hoffer M.J.V., De Vries J.W.A., Leschot N.J., Gerris J.,
RA   van der Veen F.;
RT   "Partial DAZ deletions in a family with five infertile brothers.";
RL   Fertil. Steril. 79:1652-1655(2003).
CC   -!- FUNCTION: RNA-binding protein that plays an essential role in
CC       spermatogenesis. May act by binding to the 3'-UTR of mRNAs and
CC       regulating their translation.
CC   -!- SUBUNIT: Forms a heterodimer with BOLL and DAZL. Interacts with PUM2,
CC       DAZAP1, DAZAP2, DZIP1 and DZIP3. {ECO:0000269|PubMed:10857750,
CC       ECO:0000269|PubMed:10903443, ECO:0000269|PubMed:11390979,
CC       ECO:0000269|PubMed:12511597}.
CC   -!- INTERACTION:
CC       Q13117-3; P54253: ATXN1; NbExp=3; IntAct=EBI-13357576, EBI-930964;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11058556}. Nucleus
CC       {ECO:0000269|PubMed:11058556}. Note=Predominantly cytoplasmic. Nuclear
CC       at some stages of spermatozoide development. Localizes both to the
CC       nuclei and cytoplasm of spermatozoide differentiation. Nuclear in fetal
CC       gonocytes and in spermatogonial nuclei. It then relocates to the
CC       cytoplasm during male meiosis.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q13117-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13117-2; Sequence=VSP_009452;
CC       Name=3;
CC         IsoId=Q13117-3; Sequence=VSP_009453;
CC   -!- TISSUE SPECIFICITY: Testis specific. {ECO:0000269|PubMed:10936047}.
CC   -!- DOMAIN: The DAZ domains are essential and mediate the interaction with
CC       DAZAP1 and DAZAP2.
CC   -!- POLYMORPHISM: The number as well as the precise structure of the DAZ
CC       proteins probably differs within the population.
CC       {ECO:0000305|PubMed:12752250}.
CC   -!- DISEASE: Spermatogenic failure Y-linked 2 (SPGFY2) [MIM:415000]: A
CC       disorder resulting in the absence (azoospermia) or reduction
CC       (oligozoospermia) of sperm in the semen, leading to male infertility.
CC       {ECO:0000269|PubMed:11095434, ECO:0000269|PubMed:11870237,
CC       ECO:0000269|PubMed:12801575}. Note=The disease may be caused by
CC       variants affecting the gene represented in this entry. AZFc deletions
CC       in the Yq11.23 region including the DAZ genes are the most common known
CC       genetic cause of human male infertility.
CC   -!- MISCELLANEOUS: The DAZ proteins (DAZ, DAZ2, DAZ4 and DAZ4) are all
CC       encoded by a strongly repeated region of the Y chromosome, in two
CC       clusters each comprising an inverted pair of DAZ genes. They are very
CC       similar, which gives their indidual characterization difficult. Thus,
CC       most experiments do not discriminate between the different members. One
CC       can therefore suppose that reported interactions with a DAZ protein
CC       involve all the 4 proteins.
CC   -!- SIMILARITY: Belongs to the RRM DAZ family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01238}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U21663; AAB02393.1; -; mRNA.
DR   EMBL; AF248480; AAF91329.1; -; mRNA.
DR   EMBL; AF414184; AAL24502.1; -; mRNA.
DR   EMBL; AC006338; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC113006; AAI13007.1; -; mRNA.
DR   CCDS; CCDS35485.1; -. [Q13117-1]
DR   CCDS; CCDS48210.1; -. [Q13117-3]
DR   CCDS; CCDS65375.1; -. [Q13117-2]
DR   PIR; I38963; I38963.
DR   RefSeq; NP_001005785.1; NM_001005785.2. [Q13117-3]
DR   RefSeq; NP_001005786.2; NM_001005786.2.
DR   RefSeq; NP_065096.2; NM_020363.3. [Q13117-1]
DR   SMR; Q13117; -.
DR   BioGRID; 121347; 16.
DR   IntAct; Q13117; 1.
DR   iPTMnet; Q13117; -.
DR   PhosphoSitePlus; Q13117; -.
DR   BioMuta; DAZ2; -.
DR   DMDM; 218512098; -.
DR   PaxDb; Q13117; -.
DR   PeptideAtlas; Q13117; -.
DR   PRIDE; Q13117; -.
DR   ProteomicsDB; 59168; -. [Q13117-1]
DR   ProteomicsDB; 59169; -. [Q13117-2]
DR   ProteomicsDB; 59170; -. [Q13117-3]
DR   Antibodypedia; 21892; 125 antibodies.
DR   Ensembl; ENST00000382306; ENSP00000371743; ENSG00000205944. [Q13117-3]
DR   Ensembl; ENST00000382424; ENSP00000371861; ENSG00000205944. [Q13117-1]
DR   Ensembl; ENST00000382433; ENSP00000371870; ENSG00000205944. [Q13117-1]
DR   Ensembl; ENST00000382449; ENSP00000371887; ENSG00000205944. [Q13117-3]
DR   GeneID; 57055; -.
DR   KEGG; hsa:57055; -.
DR   UCSC; uc022con.2; human. [Q13117-1]
DR   CTD; 57055; -.
DR   DisGeNET; 57055; -.
DR   GeneCards; DAZ2; -.
DR   GeneReviews; DAZ2; -.
DR   HGNC; HGNC:15964; DAZ2.
DR   HPA; ENSG00000205944; Group enriched (stomach, testis).
DR   MalaCards; DAZ2; -.
DR   MIM; 400026; gene.
DR   MIM; 415000; phenotype.
DR   neXtProt; NX_Q13117; -.
DR   OpenTargets; ENSG00000205944; -.
DR   Orphanet; 1646; Partial chromosome Y deletion.
DR   PharmGKB; PA27150; -.
DR   VEuPathDB; HostDB:ENSG00000205944.11; -.
DR   GeneTree; ENSGT00530000063480; -.
DR   InParanoid; Q13117; -.
DR   PhylomeDB; Q13117; -.
DR   TreeFam; TF324396; -.
DR   PathwayCommons; Q13117; -.
DR   BioGRID-ORCS; 57055; 8 hits in 123 CRISPR screens.
DR   ChiTaRS; DAZ2; human.
DR   GeneWiki; DAZ2; -.
DR   GenomeRNAi; 57055; -.
DR   Pharos; Q13117; Tbio.
DR   PRO; PR:Q13117; -.
DR   Proteomes; UP000005640; Chromosome Y.
DR   RNAct; Q13117; protein.
DR   Bgee; ENSG00000205944; Expressed in fundus of stomach and 17 other tissues.
DR   ExpressionAtlas; Q13117; baseline and differential.
DR   Genevisible; Q13117; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; TAS:ProtInc.
DR   GO; GO:0008494; F:translation activator activity; IBA:GO_Central.
DR   GO; GO:0070935; P:3'-UTR-mediated mRNA stabilization; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0045948; P:positive regulation of translational initiation; IBA:GO_Central.
DR   GO; GO:0007338; P:single fertilization; TAS:ProtInc.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   CDD; cd12672; RRM_DAZL; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR037366; BOULE/DAZ.
DR   InterPro; IPR034778; DAZ1-4.
DR   InterPro; IPR043628; DAZ_dom.
DR   InterPro; IPR037551; DAZ_RRM_vert.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR11176; PTHR11176; 10.
DR   PANTHER; PTHR11176:SF8; PTHR11176:SF8; 10.
DR   Pfam; PF18872; Daz; 15.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS51890; DAZ; 15.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Developmental protein; Differentiation;
KW   Nucleus; Reference proteome; Repeat; RNA-binding; Spermatogenesis.
FT   CHAIN           1..558
FT                   /note="Deleted in azoospermia protein 2"
FT                   /id="PRO_0000081555"
FT   DOMAIN          40..115
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          167..190
FT                   /note="DAZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          191..214
FT                   /note="DAZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          215..238
FT                   /note="DAZ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          239..262
FT                   /note="DAZ 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          263..286
FT                   /note="DAZ 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          287..310
FT                   /note="DAZ 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          311..334
FT                   /note="DAZ 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          335..358
FT                   /note="DAZ 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          359..382
FT                   /note="DAZ 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          383..406
FT                   /note="DAZ 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          407..430
FT                   /note="DAZ 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          431..454
FT                   /note="DAZ 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          455..478
FT                   /note="DAZ 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          479..502
FT                   /note="DAZ 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   DOMAIN          503..526
FT                   /note="DAZ 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01238"
FT   VAR_SEQ         198..389
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7670487"
FT                   /id="VSP_009452"
FT   VAR_SEQ         321..344
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_009453"
FT   CONFLICT        341
FT                   /note="N -> S (in Ref. 2; AAF91329)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        344
FT                   /note="V -> F (in Ref. 2; AAF91329)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        407
FT                   /note="A -> P (in Ref. 1; AAB02393)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        420
FT                   /note="T -> A (in Ref. 1; AAB02393)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   558 AA;  63111 MW;  D354ED2CC2AB6C35 CRC64;
     MSAANPETPN STISREASTQ SSSAAASQGW VLPEGKIVPN TVFVGGIDAR MDETEIGSCF
     GRYGSVKEVK IITNRTGVSK GYGFVSFVND VDVQKIVGSQ IHFHGKKLKL GPAIRKQKLC
     ARHVQPRPLV VNPPPPPQFQ NVWRNPNTET YLQPQITPNP VTQHVQAYSA YPHSPGQVIT
     GCQLLVYNYQ EYPTYPDSAF QVTTGYQLPV YNYQPFPAYP RSPFQVTAGY QLPVYNYQAF
     PAYPNSPFQV ATGYQFPVYN YQPFPAYPSS PFQVTAGYQL PVYNYQAFPA YPNSPFQVAT
     GYQFPVYNYQ AFPAYPNSPV QVTTGYQLPV YNYQAFPAYP NSPVQVTTGY QLPVYNYQAF
     PAYPSSPFQV TTGYQLPVYN YQAFPAYPSS PFQVTTGYQL PVYNYQAFPA YPSSPFQVTT
     GYQLPVYNYQ AFPAYPSSPF QVTTGYQLPV YNYQAFPAYP SSPFQVTTGY QLPVYNYQAF
     PAYPSSPFQV TTGYQLPVYN YQAFPAYPNS AVQVTTGYQF HVYNYQMPPQ CPVGEQRRNL
     WTEAYKWWYL VCLIQRRD
//
